Emodin 6-O-β-D-glucoside NEW
| Price | $73 | $179 | $289 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Emodin 6-O-β-D-glucoside | CAS No.: 34298-85-6 |
| Purity: 97.61% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Emodin 6-O-β-D-glucoside |
| Description | Emodin 6-O-β-D-glucoside (Glucoemodin) can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock. Emodin 6-O-beta-D-glucoside has anti-inflammatory activities and also may have significant therapeutic benefits against diabetic complications and atherosclerosis. |
| In vitro | Emodin-6-O-β-D-glucoside (EG), a novel active compound from Reynoutria japonica, suppresses HMGB1 release, TNF-α production, and HMGB1-induced NF-κB activation in HUVECs. |
| In vivo | Emodin-6-O-β-D-glucoside (EG) inhibits HMGB1-mediated hyperpermeability and leukocyte migration in mice, and increases the survival times of CLP-administered mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 65 mg/ml (150.33 mM) |
| Keywords | atherosclerosis | Emodin 6OβDglucoside | Emodin 6-O-beta-D-glucoside | diabetic | Reynoutria | active | Inhibitor | Emodin 6-O-b-D-glucoside | Emodin 6-O-β-D-glucoside | barrier | complications | potent | japonica | protective | anti-inflammatory | Emodin 6 O β D glucoside | inhibit |
| Related Compound Libraries | Bioactive Compound Library | Traditional Chinese Medicine Monomer Library | Rare Natural Product Library | Selected Plant-Sourced Compound Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Saccharide and Glycoside Natural Product Library | Natural Product Library for HTS | Bioactive Compounds Library Max | Ancient Chinese Classical Formulas Compound Library | Food as Medicine Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP2Y
|
Chongqing Zhihe Biopharmaceutical Co., Ltd.
|
2024-01-03 | |
| $195.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
| $0.00/25kg |
VIP1Y
|
Hovane Phytochemicals Co., Ltd
|
2024-11-07 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY